معرفی
Philip Cohen is a Research Professor of Enzymology at the University of Dundee's Medical Research Council Protein Phosphorylation Unit (MRC PPU). His research focuses on protein kinases, ubiquitin systems, and innate immunity, with contributions to understanding disease mechanisms like ROSAH syndrome and lupus. He leads projects including 'Sugar Ubiquitylation' and 'Expanding the Druggable Proteome of Innate Immune Cells.' Cohen has received two lifetime achievement awards for his work in life sciences and higher education.
Research Interests: Cohen's work spans phosphorylation mechanisms, protein kinase specificity, and immune signaling pathways. His studies on ALPK1 mutations and ubiquitin-mediated processes highlight his focus on translating basic discoveries into clinical applications. Recent work explores therapeutic targets for inflammatory conditions using kinase inhibitors like pacritinib.
Awards:
- Lifetime Achievement Award: Scotland’s Life Science Industry (2023)
- Lifetime Achievement Award in Higher Education: The Herald Newspaper (2023)
Advising & Grants: Supervised 7 research projects, including roles in 14 funded initiatives totaling over £10M. Notable grants include the Post-Genomics and Molecular Interactions Centre (Dundee) and collaborations with the Scripps Research Institute.
Labs/Teams: Leads the MRC PPU and co-founded the Scottish Institute for Cell Signalling (SCILLS), fostering interdisciplinary research in signaling networks.
